Teva Pharmaceutical Industries (TEVA) P/FCF US GAAP (year values) |
|||||||||
| FY2021 | FY2022 | FY2023 | FY2024 | FY2025 | LTM ? | CAGR 5 years ? | |||
| P/FCF | 37.4 | 0.00 | 0.00 | 33.3 | 31.2 | 34.1 | |||
| Changes by years, y/y, % | +126% | -100% | -6% | +13.5% | |||||
Teva Pharmaceutical Industries. P/FCF
Teva Pharmaceutical Industries. P/FCF, changes, %
Teva Pharmaceutical Industries (TEVA) P/FCF US GAAP (quarter values) |
||||||||
| FY2025Q1 | FY2025Q2 | FY2025Q3 | FY2025Q4 | FY2026Q1 | LTM ? | |||
| P/FCF | 22.9 | 21.6 | 40.1 | 31.2 | 29.7 | 34.1 | ||
| Changes by years, y/y, % | +169% | -6% | +30% | |||||
| Changes by quarters, q/q, % | -31% | -6% | +86% | -22% | -5% | |||